- Both in the U.S. and around the world,
there is a bias, or even a discrimination
against women in the health care system.
Often, the diagnosis of cardiovascular diseases
or other diseases, and the treatment patterns
are based upon clinical trials, studies,
and research that have been done largely in men.
When those are superimposed on women,
women may not be getting the specific diagnosis
or treatment that they deserve for their diseases.
For cardiovascular diseases, as an example,
many of the studies on things like statins
and high blood pressure have been done largely
with male populations.
And so, how do we know the right treatment
at the right time for the right person,
if we don't have more women included in studies,
and if we don't find a way to make sure
that our treatments are specific to genders.
In modern society today, you know, women have
an equal right to be represented in the healthcare system.
Women have an equal right to have treatments
that are designed to work for them.
And we must make sure that there are not biases
in the system against women.
Women, for example, who are pregnant and have
gestational diabetes have a much higher risk
of heart disease later in their life,
and we need to get our healthcare systems
to begin asking questions of women
about what was their pregnancy like.
How can we make sure that women have
a continuous treatment of care from their physician
who might treat them in their childbearing years,
to their physicians who might be treating them
later in life.
The wider economy is certainly impacted
because of this bias.
First of all, women may not be getting
the right treatments, so that might mean multiple trips
to the doctor, multiple medications that are tested
before a women gets to the right treatment.
Secondly, some women aren't getting treated at all,
and we know that the cost of delaying healthcare
has a very significant disadvantage to the overall economy.
Thirdly, we recognize that women who are in disadvantaged
areas and may not have access to healthier food,
safe places to exercise, may not be able to manage
and control their risk of many diseases,
will be disadvantaged and the healthcare system
will pay a very steep price.
Stakeholders must come together and be willing
to have the discussion that there is a bias
against women in the healthcare system.
There must be a roadmap for how we assure that women
are included in clinical trials.
That when new drugs and new devices are developed,
that there are those that are able to work
specifically for women.
One example we often like to give, is that for patients
that have very significant heart failure,
and they may be waiting for a heart transplant,
often are given an artificial heart in this interim
time period.
And the only FDA approved artificial heart
in the United States right now, does not fit
most women's bodies.
And so if that isn't disadvantaging women,
I'm not sure what it.
Coordination among all stakeholders is critical
to remove this bias and make sure that women
have equal access to the best of our healthcare systems
and to the best of prevention and treatment strategies.
For more infomation >> 💉 Second Xolair Shot for Mast Cell Treatment ⚕ - Duration: 11:33. 



For more infomation >> Immunotherapy Being Studied As Possible Lung Cancer Treatment - Duration: 2:57. 

For more infomation >> Interventional Pain Treatment - WAVY - Duration: 4:25. 

Không có nhận xét nào:
Đăng nhận xét